UNSPSC 51332845: Chlorpromazine sulphoxide

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H19ClN2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 016U10PN9N, chemically known as 2-chloro-10-(3-(dimethylamino)propyl)phenothiazine 5-oxide, but more generally known as chlorpromazine sulphoxide, which bears US NIH Compound Identifier 70413. European Medicines Agency schedules chlorpromazine sulphoxide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06208MIG.

Most nations, for tariff purposes, schedule chlorpromazine sulphoxide under HS 29343090. SMILES: CN(C)CCCN1C2CCCCC2[S+](C3C1CC(CC3)CL)[O-].

UNSPSC 51332845 Chlorpromazine sulphoxide is a Commodity code that nominally covers a specific pharmaceutical compound, but recent state and local procurement activity shows minimal relevance to the code's abstract classification. The single recent opportunity identified—Seminole County, Florida's IFB60459723LAS for Naloxone and Drug Deactivation Systems—targets opioid-reversal medications and harm-reduction equipment rather than chlorpromazine sulphoxide, a typical antipsychotic pharmaceutical intermediate. The mismatch between the code's nominal scope and actual procurement usage suggests either a classification error in the opportunity record or a functional narrowing of the code that does not reflect its UNSPSC definition. State and local health departments and counties are the primary issuing bodies under codes in this pharmaceutical family, but the sparse recent-opportunity record limits visibility into the true demand pattern for this specific compound.

Geographic activity is concentrated in Florida based on the single recent record. Seminole County posted its IFB on June 30, 2026, with a response deadline of July 26, 2023, seeking quarterly deliveries of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually over an initial two-year term with an optional one-year renewal. The contract specifies delivery to the Seminole County Community Health Building in Sanford, Florida, with all shipping costs included in vendor proposals. Vendors must meet E-Verify compliance, maintain specified insurance coverage, and comply with potential FEMA-funded federal requirements including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations are stated. The code shows limited recent state and local activity; firms should verify whether procurement offices are misclassifying opportunities under this code or whether demand for this specific pharmaceutical is genuinely sparse in the state and local market.